Pfizer Inc.
June 23, 2026
Theater 2
Type: Company Presentation
Focus Area:
Multiline Global Biopharma
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.
Company HQ City:
New York
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
1849
Lead Product in Development:
Various
CEO
Albert Bourla
Development Phase of Lead Product
Multiple Products in Market
Exchange
NYSE
Ticker
PFE
When you expect your next catalyst update?
July 2026
What is your next catalyst (value inflection) update?
Phase 3 clinical trial readout for sigvotatug vedotin (SV), an antibody-drug conjugate (ADC) acquired from Seagen. The Be6A LUNG-01 trial evaluates SV against standard chemotherapy in second-line non-squamous non-small cell lung cancer, with results expected in mid-2026
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}